Literature DB >> 23676012

Surgical treatment of spontaneous anterior interosseous nerve palsy: a comparison between minimal incision surgery and wide incision surgery.

Kensuke Ochi1, Yukio Horiuchi, Kenichi Tazaki, Shinichiro Takayama, Takashi Matsumura.   

Abstract

Recent reports have suggested that fascicular constriction located proximal to the elbow may be the primary aetiology of spontaneous anterior interosseous nerve palsy (sAINP), and recommended interfascicular neurolysis ranging from the proximal forearm to distal upper arm (wide incision surgery: WIS) for its treatment. On the basis of these reports, it was hypothesised that, if the aetiology of sAINP was fascicular constriction, neurolysis limited proximal to the elbow (minimal incision surgery: MIS) should have similar results to those of WIS. Twenty-five surgically treated sAINP cases were retrospectively evaluated. The mean age of onset was 42.8 years, the mean preoperative period was 5.3 months, and mean follow-up period after operation was 31 months. Eleven patients underwent MIS, while 14 underwent WIS according to the patient's intention (intention-to-treat). Twenty-one patients had fascicular constriction, and no entrapment neuropathy was seen in this series. At the latest follow-up, 82% of the patients had British Medical Research Council grade of ≥4 in flexor-pollicis-longus, while 80% had grade of ≥4 in flexor-digitorum-profundus-of-the-index-finger. There were no significant differences between the results of either group. These result suggested that the aetiology of sAINP may not be external compression, but fascicular constriction, and MIS may be its favourable surgical treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23676012     DOI: 10.3109/2000656X.2012.753079

Source DB:  PubMed          Journal:  J Plast Surg Hand Surg        ISSN: 2000-6764


  1 in total

1.  Anterior Interosseous Nerve Syndrome.

Authors:  Nathan Li; Katherine Russo; Lauren Rando; Laura Gulotta-Parrish; William Sherman; Alan D Kaye
Journal:  Orthop Rev (Pavia)       Date:  2022-10-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.